129 results
8-K
EX-99.2
AXGN
Axogen Inc.
2 May 24
Axogen, Inc Reports First Quarter 2024 Financial Results
7:00am
Study of Nerve Cuffs & Avance Nerve Graft Evaluating Recovery Outcomes for the Repair of Nerve Discontinuities 22 Safety & efficacy non- inferiority … , returning normal sensation* up to 3 months earlier in gaps greater than 10 mm (p-value 0.037).32 The safety profile was consistent with previously
8-K
EX-99.1
9nwxdodv
5 Mar 24
Regulation FD Disclosure
4:29pm
8-K
EX-99.1
b4gxsr7
8 Jan 24
Regulation FD Disclosure
7:05am
8-K/A
EX-10.1
6wted9r ros9tmile3
5 Jan 24
Departure of Directors or Certain Officers
5:21pm
8-K
EX-99.2
2hx kdphzb5
7 Nov 23
Axogen, Inc Reports 2023 Third Quarter Financial Results
7:13am
8-K
EX-99.2
gx3g9w
7 Aug 23
Axogen, Inc Reports 2023 Second Quarter Financial Results
4:08pm